← Evidence map

ArticleObesity science & practice2020

Real-world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program.

Sean Wharton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32874673